What according to you is a more critical risk factor for dementia in women?
Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
16 Oct, 24EADV 2024
Key session presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, 25-28th September 2024, Amsterdam, Netherlands
16 Oct, 24EADV 2024
Key session presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, 25-28th September 2024, Amsterdam, Netherlands
17 Oct, 24Ann Neurol.
The 40-year follow-up of the Framingham Heart Study found that high scores on the Framingham Stroke Risk Profile (FSRP) significantly increased the risk of developing all-cause dementia & Alzheimer's disease (AD). Alarmingly, women faced a 2.81-fold increased risk for dementia and a 2.96-fold increase for AD, while men did not show a similar association. Diabetes & high SBP emerged as critical risk factors for women.
Pulse Check0
17 Oct, 24JAMA Dermatol.
Mothers with HS faced a 30%-60% higher likelihood of serious complications, such as hypertensive disorders, GDM & severe maternal morbidity, found a 16-yr study involving 1.3 million pregnant women. In addition to the increased risks of preterm birth & birth defects in their offspring, these women had up to 2.5 times the risk of long-term health issues, including metabolic & infectious conditions, after childbirth.
Pulse Check0
Have you encountered serious complications in pregnant patients with Hidradenitis Suppurativa?
17 Oct, 24BMC Infect Dis.
- Meta-analysis of 11 studies (N=3,548)
- Compared to standard longer regimens, 6-month BdqLzdLfxZTrd/Eto/H had two times more favorable outcomes (RR 2.2), followed by a 9–11 month combination of km/CmMfx/LfxPtoCfzZEHh (RR1.67) and 6-month BdqPaLzdMfx (RR 1.64) with significantly higher treatment completion rates
- 6BdqPaLzdMfx, 6BdqPaLzd, and 6BdqPaLzdCfz regimens had significant decreased severity of adverse events
16 Oct, 24Dig Dis Sci.
Changes in the Fibrosis-4 score correlated with liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). However, the strongest predictors of significant fibrosis were found to be comorbid diabetes mellitus (OR 2.43), obesity (OR 3.88), and baseline ALT ≥ 30 (OR 8.55). Monitoring this may be more crucial in predicting liver fibrosis progression in MASLD patients.
Pulse Check0
Which factor do you believe is the most critical predictor of significant fibrosis in MASLD patients?
23 Sep, 24
Featured
3 Oct, 24
25 Sep, 24
25 Sep, 24